Neuron Cell Mass Structure for Reproducible MEA Drug Response
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for evaluating drug responses in human-induced pluripotent stem cell-derived neurons are time-consuming, require user-specific setup, and lack reproducibility due to varying cell morphology and culture conditions, making it difficult to obtain stable and reproducible data for neurotoxicity evaluation.
Innovation Solution
A cell-containing structure is developed with a culture surface coated for neuron adhesion, containing a cell mass with a specific spontaneous firing frequency range (0.25-31.25 Hz per electrode) and electrodes for measuring electrical properties, ensuring reproducible electrophysiological drug response evaluation.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If neurons are cultured on MEA substrate following conventional methods, then drug response evaluation can be performed, but the evaluation process is time-consuming and requires user-specific cell processing and culture setup
Solution Approach 1:
The patent applies preliminary action by pre-differentiating neurons from hiPSCs and pre-culturing them to form stable cell masses with consistent morphology and function before providing the final product. This includes establishing standardized culture protocols and pre-optimizing cell differentiation conditions, so that users receive ready-to-use cell masses that require minimal additional processing and can be directly evaluated on MEA substrates.
Solution Approach 2:
The patent employs disposable cell masses that are pre-prepared and provided in a ready-to-use state. These cell masses can be directly applied to MEA substrates without requiring users to maintain long-term cell cultures or perform complex differentiation protocols. The disposable nature eliminates the need for expensive, time-consuming cell maintenance infrastructure while ensuring consistent starting conditions for each evaluation.
2Adaptability or versatility
If user-specific cell culture conditions are used, then flexibility in experimentation is maintained, but reproducibility of evaluation results decreases due to varying cell morphology and function
Solution Approach 1:
The patent applies parameter changes by establishing specific, standardized parameters for cell differentiation and culture conditions. This includes controlling factors such as differentiation time points, cell density, culture medium composition, and environmental conditions to ensure that all cell masses are produced under identical parameters. By fixing these parameters, the patent achieves consistent cell morphology and function across different batches and users, thereby ensuring high reproducibility while maintaining the ability to test various drug compounds.
3Measurement precision
If hiPSC-derived neurons are used for evaluation, then human-specific drug responses can be detected, but high costs are incurred for cell maintenance and differentiation
Solution Approach 1:
The patent reduces costs by performing all expensive cell maintenance and differentiation operations in advance during the manufacturing process. The pre-differentiated cell masses are provided in a ready-to-use state, eliminating the need for users to invest in expensive cell culture infrastructure, specialized media, and skilled personnel for long-term cell maintenance. This shifts the cost burden to the manufacturing stage, where economies of scale can be achieved.
Solution Approach 2:
The patent replaces expensive, long-term cell culture systems with disposable, pre-prepared cell masses. These cell masses can be directly applied to MEA substrates and used immediately for evaluation, eliminating ongoing costs for cell maintenance, differentiation reagents, and specialized equipment. The disposable nature of the cell masses significantly reduces the total cost of ownership while maintaining the ability to detect human-specific drug responses.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables ready-to-use, high-reproducibility drug response evaluation by stabilizing the evaluation process and reducing variation in firing frequency responses to test compounds, facilitating efficient pharmacological testing.
Implementation Method 1
a culture surface coated with a coating agent to which the neurons are able to be adhered
Implementation Method 2
a plurality of electrodes for measuring the electrical property of the cell mass, wherein the method comprises a step of determining that a spontaneous firing frequency of cells contained in the cell mass is 0.25 Hz or more, and less than 31.25 Hz, per electrode
Data Source
Figure 1~2
Figure 3~4
Figure 5~6
AI summary
A cell-containing structure is provided that allows ready-to-use nerve drug response evaluation with high reproducibility to be easily performed. The cell-containing structure for evaluating an electrical property of neurons includes: (a) a culture surface to which the neurons are able to be adhered; (b) a cell mass that is adhered to the culture surface and contains at least one of the neurons; and (c) a plurality of electrodes for measuring the electrical property of the cell mass, wherein a spontaneous firing frequency of cells contained in the cell mass is 0.25 Hz or more per electrode.